Project Number 5P50AG005138-33 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells Research Categorization Primary Disease / Condition Alzheimer's Disease Vascular Dementia/Dysfunction CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 10. Metabolism and Bioenergetics b. Insulin Resistance and Type II Diabetes Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator BUETTNER, CHRISTOPH Principal Investigator First Name CHRISTOPH Principal Investigator Last Name BUETTNER Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-15-002: Alzheimer's Disease Research Centers (P50) FY Overall Cost $222,303 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 Mount Siniai School of Medicine Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
